Inactivated Poliovirus Vaccine [EPC]
This page covers all Inactivated Poliovirus Vaccine [EPC] drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Immune system.
Targets
Marketed (1)
- Post - Vaccination · Pfizer · Immunology
Phase 3 pipeline (3)
- IMOVAX Polio® · GlaxoSmithKline · Immunology / Infectious Disease
IMOVAX Polio is an inactivated poliovirus vaccine that stimulates the immune system to produce antibodies against all three poliovirus serotypes, providing protection against poliomyelitis. - ROTAVAC 5C -F1 · Bharat Biotech International Limited · Immunology / Infectious Disease
ROTAVAC 5C-F1 is a live attenuated rotavirus vaccine that stimulates immune responses against rotavirus to prevent gastroenteritis. - hepatitis A inactivated virus vaccine · GlaxoSmithKline · Immunology
This vaccine works by exposing the body to a small, harmless piece of the hepatitis A virus, prompting the immune system to produce antibodies that can fight the virus.
Phase 2 pipeline (1)
- CAIVT 10^5 · MedImmune LLC · Respiratory
CAIVT 10^5 is a live attenuated virus vaccine.
Patent intelligence
- virus vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates